Italy-based healthcare agency, consultancy and digital health group, Healthware, and the Digital Therapeutics Alliance, a nonprofit organization based in Virginia that provides thought leadership and education to advance digital therapeutic adoption, today announced the release of a report outlining policy pathways for digital health adoption in Europe.
Alberta Spreafico, managing director of...
Oxford Drug Design raises £2.2M to develop AI-based drug discovery programme
Biotechnology firm Oxford Drug Design Limited (ODD) has raised £2.2M in funding from existing investors ACF Investors, o2h Ventures, Meltwind Advisory, several returning angels and new investors and the US-based R42 Group.
The Oxford University spinout has created an artificial intelligence (AI) AI proprietary platform...
SELF-MANAGEMENT PLATFORM FOR IBD PATIENTS
Social purpose company, Ampersand Health has announced its partnership with Worcestershire Acute Hospitals NHS trust to roll out the inflammatory bowel disease (IBD) platform My IBD Care.
The initiative supports patients living with Crohn's disease and Ulcerative colitis and facilitates remote monitoring and communications between these patients and...
With a new coronavirus variant afoot and an uncertain 12 months ahead, MobiHealthNews has compiled 2021 predictions on the key themes that will affect the digital health industry during a potentially turbulent year. We hear from a range of EMEA-based health and tech leaders on the continued efforts to close the health equity gap, the growth of self-care apps, VR technology, employer technology...
